FIELD: pharmacology.
SUBSTANCE: claimed invention relates to field of medications, in particular, to application of Rhodamine 6G in form of 9-(2-etoxycarbonyl)phenyl)-3,6-bis(ethylamino)2,7-dimegylxantyl chloride with chemical formula C28H31N2O3CI as medication for amyloidoses treatment.
EFFECT: describes Rhodamine 6G application with novel purpose.
5 cl, 4 tbl, 17 ex
Authors
Dates
2009-05-10—Published
2007-03-16—Filed